Coronavirus Update: After Rumors Of Shortcut To Market, AZ Pledges To ‘Follow Science’ In Vaccine Trials

Plus: Moderna Confirms Japan Vaccine Supply Discussions

The company reiterates core values to 'follow the science' and 'put patients first' after talk of an emergency use authorization without completing Phase III trials.

Sign
The wearing of face masks in public is now mandatory in Paris, and several surrounding areas, following a surge in COVID-19 cases in France.

AstraZeneca PLC has launched its global Phase III trial of its COVID-19 vaccine candidate, and has addressed rumors that the US Food and Drug Administration could grant it an emergency use authorization (EUA) before this trial is complete.

Announcing the start of the trials recruiting up to 30,000 people in the US, the company pledged on 31 August...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip